Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 237

1.

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes.

Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L.

Diabetes Care. 2000 May;23(5):583-8.

PMID:
10834413
[PubMed - indexed for MEDLINE]
Free Article
2.

[Postprandial glycemic control using insulin aspart with NPH in inadequately controlled diabetics].

Gao Y, Pan CY, Zou DJ, Xu ZR, Liu XM, Guo XH.

Zhonghua Yi Xue Za Zhi. 2009 Jul 28;89(28):1960-3. Chinese.

PMID:
19950569
[PubMed - indexed for MEDLINE]
3.

Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.

Danne T, Råstam J, Odendahl R, Näke A, Schimmel U, Szczepanski R, Moeller J, Deiss D.

Pediatr Diabetes. 2007 Oct;8(5):278-85.

PMID:
17850471
[PubMed - indexed for MEDLINE]
4.

Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study.

Tamás G, Marre M, Astorga R, Dedov I, Jacobsen J, Lindholm A; Insulin Aspart Study Goup.

Diabetes Res Clin Pract. 2001 Nov;54(2):105-14.

PMID:
11640994
[PubMed - indexed for MEDLINE]
5.

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

Clin Ther. 2004 May;26(5):724-36.

PMID:
15220016
[PubMed - indexed for MEDLINE]
6.

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

Lalli C, Ciofetta M, Del Sindaco P, Torlone E, Pampanelli S, Compagnucci P, Cartechini MG, Bartocci L, Brunetti P, Bolli GB.

Diabetes Care. 1999 Mar;22(3):468-77.

PMID:
10097931
[PubMed - indexed for MEDLINE]
Free Article
7.

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group.

Diabet Med. 2000 Nov;17(11):762-70.

PMID:
11131100
[PubMed - indexed for MEDLINE]
8.

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

Ciofetta M, Lalli C, Del Sindaco P, Torlone E, Pampanelli S, Mauro L, Chiara DL, Brunetti P, Bolli GB.

Diabetes Care. 1999 May;22(5):795-800.

PMID:
10332684
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.

Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA.

Diabetologia. 2004 Apr;47(4):622-9.

PMID:
15298338
[PubMed - indexed for MEDLINE]
11.
12.

Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.

Ahmed AB, Mallias J, Home PD.

Diabetes Care. 1998 Jul;21(7):1162-6.

PMID:
9653613
[PubMed - indexed for MEDLINE]
13.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
[PubMed - indexed for MEDLINE]
14.

Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.

Sargin H, Sargin M, Altuntaş Y, Sengül AM, Orbay E, Seber S, Uçak S, Yayla A.

Diabetes Res Clin Pract. 2003 Nov;62(2):79-86.

PMID:
14581144
[PubMed - indexed for MEDLINE]
15.

Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.

Holcombe JH, Zalani S, Arora VK, Mast CJ; Lispro in Adolescents Study Group.

Clin Ther. 2002 Apr;24(4):629-38.

PMID:
12017407
[PubMed - indexed for MEDLINE]
16.

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

Imbergamo MP, Amato MC, Sciortino G, Gambina M, Accidenti M, Criscimanna A, Giordano C, Galluzzo A.

Clin Ther. 2008 Aug;30(8):1476-84. doi: 10.1016/j.clinthera.2008.08.013.

PMID:
18803989
[PubMed - indexed for MEDLINE]
17.

Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

Diabetes Care. 2003 May;26(5):1490-6.

PMID:
12716810
[PubMed - indexed for MEDLINE]
18.
19.

Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.

Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, Landin-Olsson M, Hylleberg B, Lang H, Draeger E; Study to Evaluate the Administration of Detemir Insulin Efficacy, Safety and Suitability (STEADINESS) Study Group.

Diabetes Care. 2004 May;27(5):1081-7.

PMID:
15111525
[PubMed - indexed for MEDLINE]
20.

A direct efficacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes.

Bretzel RG, Arnolds S, Medding J, Linn T.

Diabetes Care. 2004 May;27(5):1023-7.

PMID:
15111514
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk